Health Startup Noom Adding GLP-1 Drugs to Med Plan Now
Noom is shifting from psychology-based weight loss to prescription treatments, launching Noom Med in a multi-state ro...
At retirement, target date funds typically rebalance toward conservative assets, adjusting to support withdrawals while aiming to preserve principal.
20,347 articlesNoom is shifting from psychology-based weight loss to prescription treatments, launching Noom Med in a multi-state ro...
As NIO reports its first quarterly profit, the market weighs durability vs. growth. This in-depth look breaks down ho...
Investors are eyeing aemetis (amtx) 2025 earnings as the company advances its biofuels and biochemicals projects. Thi...
U.S. stocks rise as inflation remains stubborn, oil prices jump, and growth slows. The Nasdaq Composite leads gains a...
Analysts say bitcoin’s price running same playbook is resurfacing, with a key $65,000 level in focus. A potential, if...
A bold investing thesis centers on a single nuclear stock with big plans for small modular reactors and recycled fuel...
Dell Technologies rode a wave of AI server demand to a $33.4 billion quarterly revenue, beating expectations and lift...
As Assertio prepares to discuss its Q4 2025 results, investors look for clues about product performance, margins, and...
Mastercard plans to buy London-based BVNK for up to $1.8 billion, creating the largest stablecoin deal to date and ac...
As AI buzz grows, blockbuster stocks are priced to perfection. This article explores a contrarian AI stock idea that ...
A seasoned investor quietly built a multi-million stake in a fast-moving chemicals firm. This article breaks down the...
Uber unveils a multiyear pact to invest up to $1.25 billion in Rivian, aiming to roll out up to 50,000 autonomous Riv...